Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Lozanoc 65 mg in Prophylaxis
NCT02755857Phase 2Completed
- Sponsor
- Mayne Pharma
- Start
- Jul 2016
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of itraconazole in fungal infection, sponsored by Mayne Pharma. Primary endpoint: Steady-state plasma itraconazole concentrations at 3 weeks. Started Jul 2016; status: completed.
02
Drugs
itraconazole
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT02755857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755857.